Dr. David Relman on the Past, Present, and Future Potential of Microbiome in Medicine
June 5th 2017In an interview at the ASM Microbe 2017 meeting, held in New Orleans, Louisiana, Vice-Chair David Relman, MD, discussed with Contagion® microbiome research and its potential utility in medicine.
Read More
New Technologies for Detecting Antimicrobial Susceptibility and Resistance
March 8th 2017Romney Humphries, PhD, D(ABMM), section chief of Clinical Microbiology at the University of California, Los Angeles, sat down with Contagion™ to discuss antimicrobial susceptibility and resistance and new technologies in the field.
Read More
Does Vertical Zika Transmission Occur With All Infected Pregnant Women?
September 27th 2016Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses whether or not all Zika-infected pregnant women will infect their fetuses.
Read More
Do All Babies Congenitally Infected with Zika Develop Microcephaly?
September 25th 2016Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the likelihood that fetuses congenitally infected with the Zika virus will develop related complications, such as microcephaly.
Read More
Can Zika Evolve to Cause Other Complications?
September 23rd 2016Pedro Fernando da Costa Vasconcelos, MD, PhD, director of WHO Collaborating Center for Arbovirus and Research, Evandro Chagas Institute, discusses the possibility of the Zika virus evolving to cause other complications in the future.
Read More
Researching a Selective Antibacterial Effect Against Streptococcus mutans
September 16th 2016Kirk Hevener, PharmD, PhD, assistant professor of Biomedical and Pharmaceutical Sciences at Idaho State University, College of Pharmacy, explains his research regarding topoisomerase I and II enzymes.
Read More